Overview Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients Status: Completed Trial end date: 2017-11-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of Chiglitazar, compare with placebo. Phase: Phase 3 Details Lead Sponsor: Chipscreen Biosciences, Ltd.